Elemental Impurities Emerge As New Compliance Challenge

March 13th, 2019 by aveciapharma

By Adam C. Fox, Senior Vice President, Analytical Operations, Nitto Avecia Pharma Services Why is this service needed? After almost 20 years of discussion, the FDA issued new guidelines in 2018 for controlling and measuring the risk of contamination within pharmaceutical products due to the presence...

Read Full Story »

Posted in: BioProcess Online, Outsourced Pharma


Back to Top
Cal. Civ. Code ยง 1798.102 - Do Not Sell My Personal Information